The successful completion of Factory Acceptance Testing for Enovix's Gen2 Agility Line is a positive development, indicating that the company is advancing in its manufacturing capabilities. This progress is likely to be viewed favorably by investors, as it suggests potential for increased production efficiency and product quality, leading to higher demand and sales in the future. Consequently, this news has a direct positive impact on Enovix's stock price in the short term.